Perspective on measurable residual disease testing in acute myeloid leukemia von Walter, Roland B.

Volltext

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission? von Araki, Daisuke, Wood, Brent L, Othus, Megan, Radich, Jerald P, Halpern, Anna B, Zhou, Yi, Mielcarek, Marco, Estey, Elihu H, Appelbaum, Frederick R, Walter, Roland B

Volltext

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party von Schuurhuis, Gerrit J., Heuser, Michael, Freeman, Sylvie, Béné, Marie-Christine, Buccisano, Francesco, Cloos, Jacqueline, Grimwade, David, Haferlach, Torsten, Hills, Robert K., Hourigan, Christopher S., Jorgensen, Jeffrey L., Kern, Wolfgang, Lacombe, Francis, Maurillo, Luca, Preudhomme, Claude, van der Reijden, Bert A., Thiede, Christian, Venditti, Adriano, Vyas, Paresh, Wood, Brent L., Walter, Roland B., Döhner, Konstanze, Roboz, Gail J., Ossenkoppele, Gert J.

Volltext

Measurable residual disease in haematological and solid cancers von Walter, Roland B., Gale, Robert Peter

Volltext

Targeting MCL-1 in hematologic malignancies: Rationale and progress von Wei, Andrew H., Roberts, Andrew W., Spencer, Andrew, Rosenberg, Aaron Seth, Siegel, David, Walter, Roland B., Caenepeel, Sean, Hughes, Paul, McIver, Zach, Mezzi, Khalid, Morrow, Phuong Khanh, Stein, Anthony

Volltext

The present and future of measurable residual disease testing in acute myeloid leukemia von Blachly, James S, Walter, Roland B, Hourigan, Christopher S

Volltext

Acute myeloid leukemia stem cells and CD33-targeted immunotherapy von Walter, Roland B., Appelbaum, Frederick R., Estey, Elihu H., Bernstein, Irwin D.

Volltext

The past and future of CD33 as therapeutic target in acute myeloid leukemia von Laszlo, George S, Estey, Elihu H, Walter, Roland B

Volltext

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia von Green, Margaret L., Leisenring, Wendy M., Xie, Hu, Walter, Roland B., Mielcarek, Marco, Sandmaier, Brenda M., Riddell, Stanley R., Boeckh, Michael

Volltext

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis von Buckley, Sarah A, Wood, Brent L, Othus, Megan, Hourigan, Christopher S, Ustun, Celalettin, Linden, Michael A, DeFor, Todd E, Malagola, Michele, Anthias, Chloe, Valkova, Veronika, Kanakry, Christopher G, Gruhn, Bernd, Buccisano, Francesco, Devine, Beth, Walter, Roland B

Volltext

A Microdosimetric-Kinetic Model of Cell Killing by Irradiation from Permanently Incorporated Radionuclides von Hawkins, Roland B.

Volltext

Evaluating measurable residual disease in acute myeloid leukemia von Ravandi, Farhad, Walter, Roland B., Freeman, Sylvie D.

Volltext

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study von Wei, Andrew H, Strickland, Jr, Stephen A, Hou, Jing-Zhou, Fiedler, Walter, Lin, Tara L, Walter, Roland B, Enjeti, Anoop, Tiong, Ing Soo, Savona, Michael, Lee, Sangmin, Chyla, Brenda, Popovic, Relja, Salem, Ahmed Hamed, Agarwal, Suresh, Xu, Tu, Fakouhi, Kaffa M, Humerickhouse, Rod, Hong, Wan-Jen, Hayslip, John, Roboz, Gail J

Volltext

Applications of DNA microarrays in biology von Stoughton, Roland B

Volltext

Minimal Residual Disease Testing After Induction Chemotherapy for Acute Myeloid Leukemia: Moving Beyond Prognostication? von Walter, Roland B

Volltext

It's All About CareerSKILLS: Effectiveness of a Career Development Intervention for Young Employees von Akkermans, Jos, Brenninkmeijer, Veerle, Schaufeli, Wilmar B., Blonk, Roland W. B.

Volltext

Reducing GaN-on-diamond interfacial thermal resistance for high power transistor applications von Sun, Huarui, Simon, Roland B., Pomeroy, James W., Francis, Daniel, Faili, Firooz, Twitchen, Daniel J., Kuball, Martin

Volltext

Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment von WALTER, Roland B, OTHUS, Megan, BORTHAKUR, Gautam, RAVANDI, Farhad, CORTES, Jorge E, PIERCE, Sherry A, APPELBAUM, Frederick R, KANTARJIAN, Hagop A, ESTEY, Elihu H

Volltext

CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531 von Lamba, Jatinder K, Chauhan, Lata, Shin, Miyoung, Loken, Michael R, Pollard, Jessica A, Wang, Yi-Cheng, Ries, Rhonda E, Aplenc, Richard, Hirsch, Betsy A, Raimondi, Susana C, Walter, Roland B, Bernstein, Irwin D, Gamis, Alan S, Alonzo, Todd A, Meshinchi, Soheil

Volltext

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission von Walter, Roland B., Buckley, Sarah A., Pagel, John M., Wood, Brent L., Storer, Barry E., Sandmaier, Brenda M., Fang, Min, Gyurkocza, Boglarka, Delaney, Colleen, Radich, Jerald P., Estey, Elihu H., Appelbaum, Frederick R.

Volltext